/**
 * Quick Review content for Topic 7 - Receptors, signal transduction mechanisms
 * Auto-generated by Quick Review Generator
 */
const topic7QuickReview = {
  topicId: 'topic-7',
  topicNumber: 7,
  learningObjectives: {
    'lo-1': {
      title: 'Describe the main types of signaling molecules (mediators): autocrine and paracrine signaling molecules, hormones, neurotransmitters, neurohormones.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Types of Signaling Molecules' },
        { type: 'comparison',
          left: {
            title: 'Local Signaling',
            items: [
              'Autocrine: Cell targets itself (IL-2 from T cells)',
              'Paracrine: Acts on nearby cells without entering bloodstream (histamine, NO, prostaglandins)'
            ]
          },
          right: {
            title: 'Systemic Signaling',
            items: [
              'Hormones: Released by endocrine glands into blood, travel long distances (insulin, cortisol, thyroxine)',
              'Neurohormones: Released by neurosecretory cells into blood (ADH, oxytocin)'
            ]
          }
        },
        { type: 'paragraph', text: 'Neurotransmitters: Released by neurons into synapses for very fast localized action on adjacent target cells (acetylcholine, dopamine, serotonin)' },
        { type: 'keypoint', text: 'Key distinction: Autocrine/paracrine are local; hormones/neurohormones are systemic; neurotransmitters act at synapses while neurohormones enter blood' }
      ]
    },
    'lo-2': {
      title: 'Define the terms: receptor, ligand, agonist, antagonist (competitive, non-competitive).',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Receptor-Ligand Terminology' },
        { type: 'list', intro: 'Basic terms:', items: [
          'Receptor: Specialized protein that binds signaling molecules and initiates physiological response',
          'Ligand: Any molecule that binds specifically to a receptor (neurotransmitter, hormone, drug)',
          'Agonist: Ligand that activates the receptor, mimicking natural ligand and initiating cellular response'
        ]},
        { type: 'comparison',
          left: {
            title: 'Competitive Antagonist',
            items: [
              'Binds to same site as agonist',
              'Blocks agonist from connecting to receptor',
              'Prevents receptor activation'
            ]
          },
          right: {
            title: 'Non-competitive Antagonist',
            items: [
              'Binds to allosteric site (different from agonist site)',
              'Does not compete with agonist for binding',
              'Prevents receptor activation'
            ]
          }
        },
        { type: 'keypoint', text: 'Receptor activation can cause changes in membrane potential (ionotropic/metabotropic) or activation of second messenger systems' }
      ]
    },
    'lo-3': {
      title: '>>Classification of receptors: 1. based on localization<< (cell membrane receptors, cytosolic receptors, nuclear receptors, intracellular membrane receptors (IP3, ryanodin), >>2. based on function<< (ionotropic receptors, metabotropic receptors, receptor enzymes, and enzyme-linked receptors). Ionotropic receptors: selective and non-selective receptors, cation and anion channels. Give 1-1 examples.',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Receptor Classification', critical: true },
        { type: 'list', intro: 'Based on localization:', critical: true, items: [
          'Membrane receptors: Located on cell surface',
          'Cytosolic receptors: Located in cytoplasm',
          'Nuclear receptors: Located in nucleus',
          'Intracellular membrane receptors: IP3 and ryanodine receptors on ER'
        ]},
        { type: 'list', intro: 'Based on function:', critical: true, items: [
          'Ionotropic: Ligand-gated ion channels (fast)',
          'Metabotropic: G-protein coupled (slower)',
          'Receptor enzymes: Intrinsic enzymatic activity',
          'Enzyme-linked: Associated with enzymes'
        ]},
        { type: 'header', text: 'Ionotropic Receptors - Selective Channels' },
        { type: 'comparison',
          left: {
            title: 'Selective Cation Channel',
            items: [
              'Example: Nicotinic ACh receptor (nAChR)',
              'Selective for Na+ and K+',
              'Causes depolarization',
              'Found at neuromuscular junction'
            ]
          },
          right: {
            title: 'Selective Anion Channel',
            items: [
              'Example: GABA-A receptor',
              'Selective for Cl- ions',
              'Causes hyperpolarization',
              'Inhibitory response'
            ]
          }
        },
        { type: 'paragraph', text: 'Non-selective receptors allow passage of multiple ion types through the channel' }
      ]
    },
    'lo-4': {
      title: 'Metabotropic receptors: types (G-protein coupled receptors, tyrosin-kinase receptors etc).',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Metabotropic Receptor Types' },
        { type: 'paragraph', text: 'Metabotropic receptors do not form ion channels but initiate intracellular signaling cascades upon ligand binding' },
        { type: 'steps', intro: 'G-protein coupled receptors (GPCRs):', items: [
          'Structure: Seven transmembrane alpha-helices',
          'Extracellular binding site for ligands (neurotransmitters, hormones)',
          'Intracellular binding site for G-proteins',
          'Ligand binding → conformational change',
          'Activates G-protein by GDP/GTP exchange on alpha subunit',
          'Example: Muscarinic ACh receptor'
        ]},
        { type: 'steps', intro: 'Tyrosine kinase receptors (RTKs):', items: [
          'Extracellular ligand-binding domain',
          'Single transmembrane domain',
          'Intracellular domain with intrinsic tyrosine kinase activity',
          'Ligand binding causes receptor dimerization',
          'Autophosphorylation of tyrosine residues',
          'Phosphorylated sites recruit signaling proteins (SH2/PTB domains)'
        ]},
        { type: 'keypoint', text: 'GPCRs use G-proteins for signal transduction; RTKs have intrinsic enzyme activity for direct phosphorylation' }
      ]
    },
    'lo-5': {
      title: 'Heterotrimer G-proteins, types (Gs/Gi/Gq), functions.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Heterotrimeric G-proteins' },
        { type: 'steps', intro: 'G-protein activation cycle:', items: [
          'Inactive state: Alpha subunit binds GDP, associated with beta-gamma subunits',
          'Receptor binding causes GDP-GTP exchange on alpha subunit',
          'Alpha subunit dissociates from beta-gamma and activates effectors',
          'Signal termination: Alpha subunit hydrolyzes GTP to GDP',
          'Alpha subunit reassociates with beta-gamma subunits'
        ]},
        { type: 'table',
          headers: ['Type', 'Function', 'Mechanism', 'Effect'],
          rows: [
            ['Gs (stimulatory)', 'Activates adenylyl cyclase', 'ATP → cAMP', 'Activates PKA → phosphorylates targets'],
            ['Gi (inhibitory)', 'Inhibits adenylyl cyclase', 'Decreases cAMP', 'Reduces PKA activity → modulates channels/release'],
            ['Gq', 'Activates phospholipase C', 'PIP2 → IP3 + DAG', 'IP3 releases Ca2+, DAG activates PKC']
          ]
        },
        { type: 'keypoint', text: 'Gs stimulates, Gi inhibits, Gq uses calcium/PKC pathway' }
      ]
    },
    'lo-6': {
      title: '>>Define the term second messengers, describe the most important members<< (cAMP, cGMP, calcium, IP3/DAG).',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Second Messengers', critical: true },
        { type: 'paragraph', text: 'Second messengers are intracellular signaling molecules released when first messengers (hormones/neurotransmitters) bind to cell surface receptors. They amplify signal strength and facilitate cellular processes.', critical: true },
        { type: 'table', critical: true,
          headers: ['Second Messenger', 'Production', 'Degradation', 'Action', 'Example'],
          rows: [
            ['cAMP', 'Adenylyl cyclase (from ATP)', 'Phosphodiesterase', 'Activates PKA → phosphorylates targets', 'Epinephrine → glycogen breakdown'],
            ['cGMP', 'Guanylyl cyclase (from GTP)', 'Phosphodiesterase', 'Activates PKG → vasodilation, smooth muscle relaxation', 'NO signaling in blood vessels'],
            ['Ca2+', 'IP3 receptors on ER, Ca2+ channels', 'Ca2+ pumps', 'Binds calmodulin → activates Ca2+-dependent enzymes', 'Muscle contraction'],
            ['IP3', 'PLC hydrolyzes PIP2', 'Phosphatase', 'Binds ER receptors → releases Ca2+ into cytoplasm', 'Calcium signaling pathways'],
            ['DAG', 'PLC hydrolyzes PIP2', 'Lipase', 'Activates PKC (remains in membrane)', 'Growth, differentiation, metabolism']
          ]
        },
        { type: 'keypoint', text: 'cAMP/cGMP activate protein kinases; Ca2+ binds calmodulin; IP3 releases Ca2+ from ER; DAG activates PKC', critical: true }
      ]
    },
    'lo-7': {
      title: 'Explain the importance of posttranslational modification (eg. phosphorylation) to control the activity of cellular proteins.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Posttranslational Modification (PTM)' },
        { type: 'paragraph', text: 'PTMs are chemical changes to proteins after synthesis, regulating function, location, and stability without requiring new protein synthesis' },
        { type: 'steps', intro: 'Phosphorylation mechanism:', items: [
          'Reversible addition of phosphate group to Ser/Thr/Tyr',
          'Added by kinases (e.g., PKA, PKC, tyrosine kinases)',
          'Removed by phosphatases',
          'Can activate or inactivate enzymes',
          'Alters protein shape and molecular interactions',
          'Enables rapid cellular responses'
        ]},
        { type: 'list', intro: 'Examples of phosphorylation in signaling:', items: [
          'Insulin signaling: Insulin receptor phosphorylates IRS proteins',
          'MAPK cascade: Sequential phosphorylation of kinases',
          'Glycogen metabolism: PKA phosphorylates enzymes to regulate breakdown/synthesis'
        ]},
        { type: 'table',
          headers: ['PTM Type', 'Function'],
          rows: [
            ['Phosphorylation', 'Signal transduction, enzyme activation/inactivation'],
            ['Ubiquitination', 'Protein degradation via proteasome'],
            ['Acetylation', 'Gene expression regulation'],
            ['Methylation', 'Chromatin structure, gene regulation'],
            ['Glycosylation', 'Membrane targeting, protein folding'],
            ['Lipidation', 'Membrane anchoring']
          ]
        },
        { type: 'keypoint', text: 'PTMs allow rapid, reversible control of protein activity enabling quick cellular responses to changing conditions' }
      ]
    },
    'lo-8': {
      title: '>>Explain the function of receptor enzymes and enzyme-linked receptors through 1-1 example.<<',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Receptor Enzymes (Intrinsic Activity)', critical: true },
        { type: 'paragraph', text: 'Receptor enzymes have intrinsic enzymatic activity. Ligand binding activates the enzymatic function within the receptor itself.', critical: true },
        { type: 'steps', intro: 'Example: Receptor Tyrosine Kinase (RTK) - Insulin Receptor:', critical: true, items: [
          'Structure: Extracellular ligand-binding domain + single transmembrane domain + intracellular catalytic domain with tyrosine kinase activity',
          'Insulin binds to extracellular domain',
          'Receptor undergoes dimerization',
          'Trans-autophosphorylation of tyrosine residues on intracellular domain',
          'Phosphorylated tyrosines serve as docking sites for signaling proteins (SH2/PTB domains)',
          'Triggers downstream pathways regulating glucose uptake in muscle and fat cells'
        ]},
        { type: 'header', text: 'Enzyme-Linked Receptors (Associated Enzyme)', critical: true },
        { type: 'paragraph', text: 'Enzyme-linked receptors are associated with an enzyme (not intrinsic). Ligand binding activates the associated enzyme.', critical: true },
        { type: 'steps', intro: 'Example: Cytokine Receptors - JAK-STAT Pathway:', critical: true, items: [
          'Structure: Extracellular ligand-binding site + transmembrane domain + intracellular non-catalytic region',
          'Cytokine binds to receptor',
          'Receptor activates associated Janus kinase (JAK) enzymes',
          'Activated JAKs phosphorylate tyrosine residues on receptor',
          'Creates docking sites for STAT proteins',
          'Phosphorylated STATs dimerize',
          'STAT dimers translocate to nucleus',
          'Act as transcription factors regulating gene expression'
        ]},
        { type: 'keypoint', text: 'RTKs have built-in kinase activity; JAK-STAT uses separate associated kinases', critical: true }
      ]
    },
    'lo-9': {
      title: 'Signal transduction via intracellular receptors: the general structure and function of cytosolic and nuclear receptors explained through 1-1 example.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Intracellular Receptors' },
        { type: 'paragraph', text: 'Intracellular receptors are located in cytosol or nucleus, bind lipid-soluble ligands (steroid/thyroid hormones) that cross membranes, and act as transcription factors' },
        { type: 'steps', intro: 'Cytosolic Receptors - Example: Glucocorticoid Receptor (GR):', items: [
          'Inactive state: GR bound to HSP90 chaperone proteins in cytoplasm',
          'Cortisol (lipid-soluble) crosses cell membrane',
          'Cortisol binds to GR',
          'GR dissociates from HSP90',
          'GR dimerizes',
          'GR translocates to nucleus',
          'Binds to glucocorticoid response elements (GREs) in DNA',
          'Activates or represses transcription of genes involved in inflammation, metabolism, stress response'
        ]},
        { type: 'steps', intro: 'Nuclear Receptors - Example: Thyroid Hormone Receptor (TR):', items: [
          'TR already present in nucleus even without ligand',
          'Without T3/T4: TR bound to DNA associated with co-repressors → represses gene transcription',
          'T3 or T4 binds to TR',
          'TR undergoes conformational change',
          'Dissociates from co-repressors',
          'Recruits co-activators',
          'Initiates transcription of genes involved in metabolism, growth, development'
        ]},
        { type: 'keypoint', text: 'Cytosolic receptors translocate to nucleus after ligand binding; nuclear receptors are already in nucleus and switch from repressor to activator mode' }
      ]
    },
    'lo-10': {
      title: 'Describe the following terms related to membrane receptors: activation, inactivation, internalization, up-regulation, down-regulation, sensitization, desensitization.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Receptor Regulation Terms' },
        { type: 'table',
          headers: ['Term', 'Definition', 'Mechanism'],
          rows: [
            ['Activation', 'Receptor triggered by ligand binding', 'Conformational change → initiates signaling cascade'],
            ['Inactivation', 'Receptor unable to respond', 'Modification, internalization, or inhibitory molecule binding'],
            ['Internalization', 'Receptors removed from membrane', 'Endocytosis → reduces active receptors → decreases sensitivity'],
            ['Up-regulation', 'Increase in receptor number', 'Response to decreased ligand → increases cell sensitivity'],
            ['Down-regulation', 'Decrease in receptor number', 'Prolonged high ligand exposure → prevents overstimulation'],
            ['Sensitization', 'Cell becomes more responsive', 'Increased receptor density or enhanced binding affinity'],
            ['Desensitization', 'Decreased receptor activity', 'Continuous/repeated ligand exposure → phosphorylation, internalization, uncoupling']
          ]
        },
        { type: 'comparison',
          left: {
            title: 'Increased Sensitivity',
            items: [
              'Up-regulation: More receptors',
              'Sensitization: Better response',
              'Occurs with low ligand availability'
            ]
          },
          right: {
            title: 'Decreased Sensitivity',
            items: [
              'Down-regulation: Fewer receptors',
              'Desensitization: Weaker response',
              'Occurs with high/prolonged ligand exposure'
            ]
          }
        },
        { type: 'keypoint', text: 'Receptor regulation maintains homeostasis by adjusting sensitivity to prevent overstimulation or maintain response during low ligand availability' }
      ]
    }
  }
};

export default topic7QuickReview;
